Combination of altered PBPs and expression of cloned extended-spectrum β-lactamases confers cefotaxime resistance in Haemophilus influenzae

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 4, 2006, Pages 747-749

  Bozdogan, Bülent ^a   Tristram, Stephen ^b   Appelbaum, Peter C ^c  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b UNIVERSITY OF TASMANIA   (Australia)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

lactams; ESBLs; H. influenzae; Penicillin binding proteins

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFPODOXIME; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN BINDING PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIFFUSION; GENETIC CODE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PENICILLIN RESISTANCE; PLASMID; PROTEIN EXPRESSION; STRAIN IDENTIFICATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOTAXIME; CEPHALOSPORIN RESISTANCE; CLONING, MOLECULAR; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS; RECOMBINATION, GENETIC;

EID: 33645120484     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl039     Document Type: Article

References (11)

1. Fluit AC, Florijn A, Verhoef J et al. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 2005; 56: 133-8.
2. Heilmann KP, Rice CL, Miller AL et al. Decreasing prevalence of β-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother 2005; 49: 2561-4.
3. Ubukata K, Shibasaki Y, Yamamoto K et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001; 45: 1693-9.
4. Dabernat H, Delmas C, Seguy M et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002; 46: 2208-18.
5. Tristram S. Effect of extended-spectrum β-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins. J Antimicrob Chemother 2003; 51: 39-43.
6. Tristram SG, Bozdogan B, Appelbaum PC. Disc diffusion-based screening tests for extended-spectrum β-lactamases in Haemophilus influenzae. J Antimicrob Chemother 2005; 55: 570-3.
7. Matic V, Bozdogan B, Jacobs MR et al. Contribution of β-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in β-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J Antimicrob Chemother 2003; 52: 1018-21.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA, 2003.
9. Barcak GJ, Chandler MS, Redfield RJ et al. Genetic systems in Haemophilus influenzae. Methods Enzymol 1991; 204: 321-42.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement M100-S15. NCCLS, Wayne, PA, USA, 2005.
11. Bradford P. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.